| Symbol
| MAGEA4
| contributors: mct/npt - updated : 04-06-2020
|
| HGNC name
| melanoma antigen family A, 4
|
| HGNC id
| 6802
|
| Other morbid association(s)
|
| Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
|---|
| tumoral
|
|
| --over
|
| |
in non-small cell lung carcinomas (Peikert 2006) | | tumoral
|
|
| --over
|
| |
in primary breast cancer | | tumoral
|
|
| --over
|
|
in a variety of malignancies in significant correlation with tumor cell invasiveness and aggressiveness  | | tumoral
|
|
| --over
|
| |
in patients with synovial sarcoma | | tumoral
|
|
| --other
|
| |
MAGEA4 immunohistochemical expressionis associated with decreased disease free and overall survival in patients with high-grade endometrial cancer | |
Variant & Polymorphism
| 
| |
Candidate gene
| Marker
| potential utility of MAGEA4 as an ancillary diagnostic marker for synovial sarcoma combined with CTAG1B | |
CTAG1B and MAGEA4 may be useful for the diagnosis of synovial sarcoma | Therapy target
|
| | |